Estratto
La dermatite atopica (DA) è una malattia infiammatoria cronica della cute, la cui incidenza e prevalenza è ancora in aumento nei paesi industrializzati [1]. Colpisce il 6%–20% dei bambini e l’ 1%–3% degli adulti [2]. La DA si manifesta con lesioni eczematose acute e croniche che si sovrappongono in relazione alla fase della malattia, ed interessano prevalentemente il volto, il collo, le aree peri- e retroauricolari e le pieghe flessorie degli arti. Nell’adulto è frequente alle mani e nelle sedi periorifiziali. Costante è la secchezza cutanea, che persiste anche nei periodi di remissione infiammatoria, e della sintomatologia pruriginosa. La DA ha tipicamente un decorso cronico-recidivante con riaccensioni più o meno severe alternate a periodi di remissione più o meno lunghi [1].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Bibliografia
Williams HC (2005) Atopic dermatitis. N Engl J Med 352:2314–2324.
Girolomoni G, Abeni D, Masini C et al (2003) The epidemiology of atopic dermatitis in Italian schoolchildren. Allergy 58:420–425.
Flohr C, Johansson SGO, Wahlgren CF, Williams H (2004) How “atopic” is atopic dermatitis? J Allergy Clin Immunol 114:150–158.
Novak N, Bieber T (2003) Allergic and nonallergic form of atopic diseases. J Allergy Clin Immunol 112:252–262.
Illi S, von Mutius E, Lau S et al (2004) Multicenter Allergy Study Group. The natural course of atopic dermatitis from birth to age 7 years and the association with asthma. J Allergy Clin Immunol 113:925–931.
Flohr C, Pascoe D, Williams H (2005) Atopic dermatitis and the “hygiene hypothesis”: too clean to be true? Br J Dermatol 152:202–216.
Zutaven A, Hirsch H, Leupold W et al (2005) Atopic dermatitis, extrinsic atopic dermatitis and the hygiene hypothesis: results from a cross-sectional study. Clin Exp Allergy 35:1301–1308.
Cork MJ, Robinson DA, Vasilopoulos Y et al (2006) New persepectives on epidermal barrier dysfunction in atopic dermatitis: gene-environment interactions. J Allergy Clin Immunol 118:3–21.
Cookson WO (2004) The immunogenetics of asthma and eczema: a new focus on the epithelium. Nat Rev Immunol 4:978–988.
Morar N, Willis-Owen SAG, Moffatt MF, Cookson WOCM (2006) The genetics of atopic dermatitis. J Allergy Clin Immunol 118:24–34.
Palmer CN, Irvine AD, Terron-Kwiatkowski A et al (2006) Common loss-of-function variants of the epidermal barrier protein filaggrin are a mjor predisposing factor for atopic dermatitis. Nat Genet 38:337–342.
Weldinger S, Illig T, Baurecht H et al (2006) Loss-of-function variations within the filaggrin gene predispose for atopic dermatitis with allergic sensitizations. J Allergy Clin Immunol 118:214–219.
Pastore S, Rogge I, Mariotti F et al (2005) Gene expression profile in keratinocytes from atopic dermatitis patients. G It Dermatol Venereol 140:475–483.
Girolomoni G, Pastore S (2001) Epithelial cells and atopic diseases. Curr Allergy Asthma Rep 1:481–482.
Pastore S, Mascia F, Girolomoni G (2006) The contribution of keratinocytes to the pathogenesis of atopic dermatitis. Eur J Dermatol 16:125–131.
Giustizieri ML, Mascia F, Frezzolini A et al (2001) Keratinocytes from patients with atopic dermatitis and psoriasis show a distinct chemokine production profile in response to T cell-derived cytokines. J Allergy Clin Immunol 107:871–877.
Girolomoni G, Mascia F, Dattilo C et al (2005) Keratinocytes in atopic dermatitis. In: Ring J, Przybilla B, Ruzicka T (eds) Handbook of atopic dermatitis, second edition. Springer-Verlag, Heidelberg, pp 330–337.
Pastore S, Giustizieri ML, Mascia F et al (2000) Dysregulated activation of activator protein 1 in keratinocytes of atopic dermatitis patients with enhanced expression of granulocyte/macrophage-colony stimulating factor. J Invest Dermatol 115:1134–1143.
Pastore S, Fanales-Belasio E, Albanesi C et al (1997) Granulocyte macrophage colony-stimulating factor is overproduced by keratinocytes in atopic dermatitis. Implications for sustained dendritic cell activation in the skin. J Clin Invest 99:3009–3017.
Soumelis V, Reche PA, Kanzler H et al (2002) Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP. Nat Immunol 3:673–680.
Garg A, Chren MM, Sands LP et al (2001) Psychological stress perturbs epidermal permeability barrier homeostasis. Arch Dermatol 137:53–59.
McGirt LY, Beck LA (2006) Innate immune defects in atopic dermatitis. J Allergy Clin Immunol 118:202–208.
Howell MD, Novak N, Bieber T et al (2005) Interleukin-10 downregulates anti-microbial peptide expression in atopic dermatitis. J Invest Dermatol 125:738–745.
Howell MD, Boguniewicz M, Pastore S et al (2006) Mechanism of HBD-3 deficiency in atopic dermatitis. Clin Immunol (in press)
Scarponi C, Nardelli B, LaFleur DW et al (2006) Analysis of IFN-k expression in pathological skin conditions: downregulation in psoriasis and atopic dermatitis. J Interferon Cytokine Res 25:133–140.
Girolomoni G, Sebastiani S, Albanesi C, Cavani A (2001) T-cell subpopulations in the development of atopic and contact allergy. Curr Opin Immunol 13:733–737.
Vulcano M, Albanesi C, Stoppacciaro A et al (2001) Dendritic cells as a major source of macrophage-derived chemokine/CCL22 in vitro and in vivo. Eur J Immunol 31:812–822.
Homey B, Steinhoff M, Ruzicka T, Leung DYM (2006) Cytokines and chemokines orchestrate atopic skin inflammation. J Allergy Clin Immunol 118:178–189.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2007 Springer-Verlag Italia
About this chapter
Cite this chapter
Girolomoni, G., Gisondi, P., Pastore, S. (2007). Dermatite atopica: eziopatogenesi. In: Gelmetti, C. (eds) La scuola dell’atopia. Springer, Milano. https://doi.org/10.1007/978-88-470-0593-8_5
Download citation
DOI: https://doi.org/10.1007/978-88-470-0593-8_5
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-0592-1
Online ISBN: 978-88-470-0593-8
eBook Packages: MedicineMedicine (R0)